371 related articles for article (PubMed ID: 29202826)
1. Autonomic nervous system involvement in pulmonary arterial hypertension.
Vaillancourt M; Chia P; Sarji S; Nguyen J; Hoftman N; Ruffenach G; Eghbali M; Mahajan A; Umar S
Respir Res; 2017 Dec; 18(1):201. PubMed ID: 29202826
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system.
Liu C; Jiang XM; Zhang J; Li B; Li J; Xie DJ; Hu ZY
BMC Cardiovasc Disord; 2016 Oct; 16(1):192. PubMed ID: 27724864
[TBL] [Abstract][Full Text] [Related]
3. Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure.
Ameri P; Bertero E; Meliota G; Cheli M; Canepa M; Brunelli C; Balbi M
Heart Fail Rev; 2016 Sep; 21(5):539-47. PubMed ID: 27206576
[TBL] [Abstract][Full Text] [Related]
4. Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension.
Huang Y; Liu YW; Pan HZ; Zhang XL; Li J; Xiang L; Meng J; Wang PH; Yang J; Jing ZC; Zhang H
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):704-718. PubMed ID: 30816802
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension.
de Man FS; Tu L; Handoko ML; Rain S; Ruiter G; François C; Schalij I; Dorfmüller P; Simonneau G; Fadel E; Perros F; Boonstra A; Postmus PE; van der Velden J; Vonk-Noordegraaf A; Humbert M; Eddahibi S; Guignabert C
Am J Respir Crit Care Med; 2012 Oct; 186(8):780-9. PubMed ID: 22859525
[TBL] [Abstract][Full Text] [Related]
6. Renal sympathetic denervation prevents the development of pulmonary arterial hypertension and cardiac dysfunction in dogs.
Hu W; Yu SB; Chen L; Guo RQ; Zhao QY
Kaohsiung J Med Sci; 2015 Aug; 31(8):405-12. PubMed ID: 26228279
[TBL] [Abstract][Full Text] [Related]
7. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.
Vonk-Noordegraaf A; Haddad F; Chin KM; Forfia PR; Kawut SM; Lumens J; Naeije R; Newman J; Oudiz RJ; Provencher S; Torbicki A; Voelkel NF; Hassoun PM
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D22-33. PubMed ID: 24355638
[TBL] [Abstract][Full Text] [Related]
8. Effects of renal denervation on monocrotaline induced pulmonary remodeling.
Liu Q; Song J; Lu D; Geng J; Jiang Z; Wang K; Zhang B; Shan Q
Oncotarget; 2017 Jul; 8(29):46846-46855. PubMed ID: 28187460
[TBL] [Abstract][Full Text] [Related]
9. Sympathetic innervation of canine pulmonary artery and morphometric and functional analysis in dehydromonocrotaline-induced models after pulmonary artery denervation.
Jiang X; Zhang J; Zhou L; Luo J; Wang J; Li L; Chen S
Interact Cardiovasc Thorac Surg; 2020 Nov; 31(5):708-717. PubMed ID: 33057705
[TBL] [Abstract][Full Text] [Related]
10. Treatment for pulmonary arterial hypertension-associated right ventricular dysfunction.
Gomez-Arroyo J; Sandoval J; Simon MA; Dominguez-Cano E; Voelkel NF; Bogaard HJ
Ann Am Thorac Soc; 2014 Sep; 11(7):1101-15. PubMed ID: 25079379
[TBL] [Abstract][Full Text] [Related]
11. Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.
Maron BA; Leopold JA
Circulation; 2015 Jun; 131(23):2079-91. PubMed ID: 26056345
[No Abstract] [Full Text] [Related]
12. Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?
de Man FS; Handoko ML; Guignabert C; Bogaard HJ; Vonk-Noordegraaf A
Am J Respir Crit Care Med; 2013 Jan; 187(1):14-9. PubMed ID: 23144327
[TBL] [Abstract][Full Text] [Related]
13. Beneficial Effects of Renal Denervation on Pulmonary Vascular Remodeling in Experimental Pulmonary Artery Hypertension.
Qingyan Z; Xuejun J; Yanhong T; Zixuan D; Xiaozhan W; Xule W; Zongwen G; Wei H; Shengbo Y; Congxin H
Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):562-70. PubMed ID: 25804321
[TBL] [Abstract][Full Text] [Related]
14. RV pressure overload: from hypertrophy to failure.
van der Bruggen CEE; Tedford RJ; Handoko ML; van der Velden J; de Man FS
Cardiovasc Res; 2017 Oct; 113(12):1423-1432. PubMed ID: 28957530
[TBL] [Abstract][Full Text] [Related]
15. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
[TBL] [Abstract][Full Text] [Related]
16. The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension.
Yap LB; Ashrafian H; Mukerjee D; Coghlan JG; Timms PM
Clin Biochem; 2004 Oct; 37(10):847-56. PubMed ID: 15369714
[TBL] [Abstract][Full Text] [Related]
17. Use of β-Blockers in Pulmonary Hypertension.
Perros F; de Man FS; Bogaard HJ; Antigny F; Simonneau G; Bonnet S; Provencher S; Galiè N; Humbert M
Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364092
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).
Chen SL; Zhang FF; Xu J; Xie DJ; Zhou L; Nguyen T; Stone GW
J Am Coll Cardiol; 2013 Sep; 62(12):1092-1100. PubMed ID: 23850902
[TBL] [Abstract][Full Text] [Related]
19. Cardiac magnetic resonance imaging: what can it add to our knowledge of the right ventricle in pulmonary arterial hypertension?
Vonk-Noordegraaf A; Souza R
Am J Cardiol; 2012 Sep; 110(6 Suppl):25S-31S. PubMed ID: 22921028
[TBL] [Abstract][Full Text] [Related]
20. Autonomic nervous modulation: early treatment for pulmonary artery hypertension.
Xueyuan L; Yanping X; Jiaoqiong G; Yuehui Y
ESC Heart Fail; 2024 Apr; 11(2):619-627. PubMed ID: 38108098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
